Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica V Rezelj

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|April 17, 2021
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hostsVeronica V Rezelj, Lucía Carrau, Fernando Merwaiss, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Plos Neglected Tropical Diseases|October 6, 2016
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, BrazilClaire L Donald, Benjamin Brennan, Stephanie L Cumberworth, et al.
Science (New York, N.Y.)|July 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Nature Cell Biology|January 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Nature Communications|September 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsKelsey M Haas, Michael J McGregor, Mehdi Bouhaddou, et al.
Cell|July 10, 2020
The Global Phosphorylation Landscape of SARS-CoV-2 InfectionMehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Nature|May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Science (New York, N.Y.)|October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsDavid E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nature Communications|April 17, 2021
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hostsVeronica V Rezelj, Lucía Carrau, Fernando Merwaiss, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Plos Neglected Tropical Diseases|October 6, 2016
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, BrazilClaire L Donald, Benjamin Brennan, Stephanie L Cumberworth, et al.
Science (New York, N.Y.)|July 30, 2021
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2Tia A Tummino, Veronica V Rezelj, Benoit Fischer, et al.
Nature Cell Biology|January 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Nature Communications|September 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsKelsey M Haas, Michael J McGregor, Mehdi Bouhaddou, et al.
Cell|July 10, 2020
The Global Phosphorylation Landscape of SARS-CoV-2 InfectionMehdi Bouhaddou, Danish Memon, Bjoern Meyer, et al.
Nature|May 1, 2020
A SARS-CoV-2 protein interaction map reveals targets for drug repurposingDavid E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, et al.
Science (New York, N.Y.)|October 16, 2020
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanismsDavid E Gordon, Joseph Hiatt, Mehdi Bouhaddou, et al.
Pageof 3